Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain

Eurosurveillance

Volumn 19, Issue 32, 2014, Pages

  Sizaire, V ^a,b   Garrido Estepa, M ^a   Masa Calles, J ^a,c   Martinez de Aragon, M V ^a,c  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; EPIDEMIC; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERTUSSIS; PRESCHOOL CHILD; SCHOOL CHILD; SPAIN; VACCINATION;

EID: 84908687083     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.32.20875     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention (CDC). Pertussis (whooping cough). Atlanta, GA: CDC. Updated 11 Jun 2012. [Accesssed 10 Apr 2013]. Available from: http://www.cdc.gov/pertussis/countries.html
2. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003;3(7):413-8. http://dx.doi.org/10.1016/S1473-3099(03)00669-8
3. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet. 2006;367(9526):1926-36. http://dx.doi.org/10.1016/S0140-6736(06)68848-X
4. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85(40):385-400.
5. Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis. 1996;174 Suppl 3:S259-63. http://dx.doi.org/10.1093/infdis/174.Supplement_3.S259
6. Deville JG, Cherry JD, Christenson PD, Pineda E, Leach CT, Kuhls TL, et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis. 1995;21(3):639-42. http://dx.doi.org/10.1093/clinids/21.3.639
7. Gay NJ, Miller E. Pertussis transmission in England and Wales. Lancet. 2000;355(9214):1553-4. http://dx.doi.org/10.1016/S0140-6736(05)74603-1
8. Schmitt-Grohé S, Cherry JD, Heininger U, Uberall MA, Pineda E, Stehr K. Pertussis in German adults. Clin Infect Dis. 1995;21(4):860-6. http://dx.doi.org/10.1093/clinids/21.4.860
9. Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol. 2012;20(5):211-3. http://dx.doi.org/10.1016/j.tim.2012.03.003
10. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis. 2002;185(10):1448-53. http://dx.doi.org/10.1086/340280
11. Cherry JD. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease. N Engl J Med. 2012;367(9):785-7. http://dx.doi.org/10.1056/NEJMp1209051
12. Shapiro ED. Acellular vaccines and resurgence of pertussis. JAMA. 2012;308(20):2149-50. http://dx.doi.org/10.1001/jama.2012.65031
13. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rümke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis. 2000;6(4):348-57. http://dx.doi.org/10.3201/eid0604.000404
14. Lavine JS, Bjørnstad ON, de Blasio BF, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine. 2012;30(3):544-51. http://dx.doi.org/10.1016/j.vaccine.2011.11.065
15. Wiese-Posselt M, Hellenbrand W. Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill. 2010;15(16):pii=19548.
16. Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill. 2013;18(38):pii=20587.
17. Riolo MA, King AA, Rohani P. Can vaccine legacy explain the British pertussis resurgence? Vaccine. 2013;31(49):5903-8. http://dx.doi.org/10.1016/j.vaccine.2013.09.020
18. Grgic-Vitek M, Klavs I, Kraigher A. Re-emergence of pertussis in Slovenia: time to change immunization policy. Vaccine. 2008;26(15):1874-8. http://dx.doi.org/10.1016/j.vaccine.2008.01.045
19. Gabutti G, Rota MC. Pertussis: a review of disease epidemiology worldwide and in Italy. Int J Environ Res Public Health. 2012;9(12):4626-38. http://dx.doi.org/10.3390/ijerph9124626
20. Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics. 2005;116(2):e285-94. http://dx.doi.org/10.1542/peds.2004-2759
21. Vickers D, Ross AG, Mainar-Jaime RC, Neudorf C, Shah S. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. CMAJ. 2006;175(10):1213-7. http://dx.doi.org/10.1503/cmaj.051637
22. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54(12):1730-5. http://dx.doi.org/10.1093/cid/cis287
23. World Health Organization (WHO). WHO-recommended standards for surveillance of selected vaccine-preventable diseases. Geneva: WHO; 2003. Available from: http://apps.who.int/iris/bitstream/10665/68334/1/WHO_V-B_03.01_eng.pdf
24. European Centre for Disease Prevention and Control (ECDC). Pertussis. Stockholm: ECDC. [Accessed 19 Dec 2013]. Available from: http://ecdc.europa.eu/en/activities/surveillance/euvac/case_definition/Pages/pertusis.aspx
25. Grupo de Trabajo Tos Ferina 2012 de la Ponencia de Programas y Registro de Vacunaciones.Revisión del programa de vacunación frente a tos ferina en Espa-a. [Review of the vaccination programme against pertussis in Spain]. Madrid: Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad; 2013. Spanish. Available from: http://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/TosFerina.pdf
26. Situación epidemiológica de la tos ferina en Espa-a. [Epidemiological situation of pertussis in Spain]. Madrid: Centro Nacional de Epidemiologia, Insituto de Salud Carlos III, Ministerio de ciencia e innovación; 11 Sep 2012. Spanish.
27. Coberturas de vacunación. Datos estadísticos. [Vaccine coverage. Statistical data]. Updated 30 Apr 2013. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad. [Accessed 30 Apr2013]. Spanish. Available from: https://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/coberturas.htm
28. CIE-9-MC.Clasificación Internacional de Enfermedades, 9ª Revisión Modificación Clínica. [International classification of diseases, 9th revision clinical modification]. 8th ed. Madrid: Ministerio de Sanidad, Política Social e Igualdad, Secretaría General Técnica; 2012. Spanish. Available from http://www.msc.es/estadEstudios/estadisticas/docs/CIE9MC_8ed.pdf
29. Güriş D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28(6):1230-7. http://dx.doi.org/10.1086/514776
30. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5 Suppl):S58-61. http://dx.doi.org/10.1097/01.inf.0000160914.59160.41
31. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011;11(7):557-70. http://dx.doi.org/10.1016/S1473-3099(11)70007-X
32. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26(4):293-9. http://dx.doi.org/10.1097/01.inf.0000258699.64164.6d
33. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 2013;131(4):e1047-52. http://dx.doi.org/10.1542/peds.2012-1928
34. Urwyler P, Heininger U. Protecting newborns from pertussis – the challenge of complete cocooning. BMC Infect Dis. 2014;14(1)397. [Epub ahead of print]. http://dx.doi.org/10.1186/1471-2334-14-397
35. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014. pii: S0140-6736(14)60686-3.
36. Matlow JN, Pupco A, Bozzo P, Koren G. Tdap vaccination during pregnancy to reduce pertussis infection in young infants. Can Fam Physiscian. 2013;59(5):497-8.
37. Conyn M, van der Maas N, Mooi F. Control of whooping cough in the Netherlands: optimisation of the vaccination policy. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2013. RIVM report 215121002/2012. Synopsis available from: http://www.rivm.nl/en/Documents_and_publications/Scientific/Reports/2013/februari/Control_of_whooping_cough_in_the_Netherlands_Optimisation_of_the_vaccination_policy:181357